×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
IBM Innovation Theater: Embracing Hybrid - How New Technologies, Synergized with Proven Solutions, Will Shape the Journey to Commonplace Decentralized Trials
Session Chair(s)
Merative
United States
While all eyes are on decentralized trial technologies to improve patient centricity, it's important to recognize the critical role that hybrid trials plays as our industry is still adapting to changes from the past two years. Join IBM Watson Health to learn how IBM clinical development users have leveraged both new decentralized trial technologies and proven cloud-based solutions to manage highly-successful hybrid trials with record-breaking cycle time.
Speaker(s)
Walker Bradham
Walker Bradham
Merative, United States
Product Leader, Zelta
Wes Fishburne
Wes Fishburne
IBM Watson Health, United States
Product Manager
Mark Laney
Mark Laney
Merative, United States
Sales Engineering & Product Partnerships Lead
Have an account?